CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,598,184 | -20.4% | 226,400 | +0.4% | 0.39% | -25.5% |
Q3 2022 | $5,779,000 | -2.4% | 225,400 | -9.5% | 0.52% | +10.1% |
Q2 2022 | $5,922,000 | +6.2% | 249,000 | +0.6% | 0.47% | +31.7% |
Q1 2022 | $5,576,000 | +72.8% | 247,600 | +33.5% | 0.36% | +13.9% |
Q3 2020 | $3,226,000 | +3.4% | 185,400 | 0.0% | 0.32% | +11.3% |
Q2 2020 | $3,119,000 | +136.1% | 185,400 | +130.9% | 0.28% | +54.3% |
Q1 2018 | $1,321,000 | -19.0% | 80,300 | -11.1% | 0.18% | -30.0% |
Q4 2017 | $1,631,000 | -6.4% | 90,300 | 0.0% | 0.26% | -10.5% |
Q3 2017 | $1,743,000 | +63.5% | 90,300 | 0.0% | 0.29% | +41.3% |
Q2 2017 | $1,066,000 | -5.8% | 90,300 | -12.6% | 0.21% | -7.6% |
Q1 2017 | $1,132,000 | – | 103,300 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |